anmelden
SLI
2.318,31
PKT
-8,99
PKT
-0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.10.18 | Holcim Neutral | JP Morgan Chase & Co. | |
| 29.10.18 | Holcim Hold | CFRA | |
| 29.10.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 29.10.18 | Holcim Underweight | Barclays Capital | |
| 29.10.18 | Swiss Re overweight | Barclays Capital | |
| 26.10.18 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 26.10.18 | Holcim Neutral | Goldman Sachs Group Inc. | |
| 26.10.18 | UBS Outperform | Credit Suisse Group | |
| 26.10.18 | UBS Sector Perform | RBC Capital Markets | |
| 26.10.18 | Holcim Neutral | JP Morgan Chase & Co. | |
| 26.10.18 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 26.10.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 26.10.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.10.18 | Holcim Neutral | UBS AG | |
| 26.10.18 | Holcim Outperform | Bernstein Research | |
| 26.10.18 | ABB (Asea Brown Boveri) Hold | CFRA | |
| 25.10.18 | UBS buy | Baader Bank | |
| 25.10.18 | UBS Underweight | Barclays Capital | |
| 25.10.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 25.10.18 | ABB (Asea Brown Boveri) buy | Société Générale Group S.A. (SG) | |
| 25.10.18 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 25.10.18 | UBS buy | Baader Bank | |
| 25.10.18 | UBS buy | CFRA | |
| 25.10.18 | ABB (Asea Brown Boveri) Hold | Baader Bank | |
| 25.10.18 | UBS Neutral | Goldman Sachs Group Inc. | |
| 25.10.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.18 | UBS overweight | JP Morgan Chase & Co. | |
| 25.10.18 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 25.10.18 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 25.10.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 25.10.18 | Novartis Hold | HSBC | |
| 24.10.18 | Swiss Re Outperform | Credit Suisse Group | |
| 24.10.18 | Givaudan overweight | JP Morgan Chase & Co. | |
| 24.10.18 | Holcim Neutral | JP Morgan Chase & Co. | |
| 23.10.18 | UBS buy | Goldman Sachs Group Inc. | |
| 23.10.18 | UBS Neutral | Goldman Sachs Group Inc. | |
| 23.10.18 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 23.10.18 | Roche Neutral | UBS AG | |
| 23.10.18 | Nestlé buy | Jefferies & Company Inc. | |
| 22.10.18 | Novartis Neutral | JP Morgan Chase & Co. |
